BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26478896)

  • 1. Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy.
    Ogata H; Yamasaki R; Hiwatashi A; Oka N; Kawamura N; Matsuse D; Kuwahara M; Suzuki H; Kusunoki S; Fujimoto Y; Ikezoe K; Kishida H; Tanaka F; Matsushita T; Murai H; Kira J
    Ann Clin Transl Neurol; 2015 Oct; 2(10):960-71. PubMed ID: 26478896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
    Kira JI
    Front Neurol; 2021; 12():665136. PubMed ID: 34177770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
    Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
    Front Neurol; 2018; 9():997. PubMed ID: 30538665
    [No Abstract]   [Full Text] [Related]  

  • 4. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
    J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
    Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
    J Neurol; 2024 May; ():. PubMed ID: 38771386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
    Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
    Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
    Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
    Querol L; Rojas-García R; Diaz-Manera J; Barcena J; Pardo J; Ortega-Moreno A; Sedano MJ; Seró-Ballesteros L; Carvajal A; Ortiz N; Gallardo E; Illa I
    Neurol Neuroimmunol Neuroinflamm; 2015 Oct; 2(5):e149. PubMed ID: 26401517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features of Autoimmune Nodopathy With Anti-Neurofascin-155 Antibodies in South Koreans.
    Lyou HJ; Chung YH; Kim MJ; Kim M; Jeon MY; Kim SW; Shin HY; Kim BJ
    J Clin Neurol; 2024 Mar; 20(2):186-193. PubMed ID: 38171501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
    Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
    Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy.
    Wang L; Pan J; Meng H; Yang Z; Zeng L; Liu J
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
    Ogata H; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Isobe N; Kira JI
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2304-2316. PubMed ID: 31657126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of Guillain-Barré syndrome with anti-neurofascin 155 antibody.
    Zhao N; Chang SH; Zhang QX; Zhang LJ; Jiang SM; Zhai H; Yang L
    Acta Neurol Scand; 2022 Nov; 146(5):553-561. PubMed ID: 36237129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China.
    Zhang X; Zheng P; Devaux JJ; Wang Y; Liu C; Li J; Guo S; Song Y; Wang Q; Feng X; Wang Y
    J Neuroimmunol; 2019 Dec; 337():577074. PubMed ID: 31693967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.
    Wang Z; Zhou X; Zhao N; Xie C; Zhu D; Guan Y
    Neurol Sci; 2021 Jun; 42(6):2223-2233. PubMed ID: 33782779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
    Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
    J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
    Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
    Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.